This information is intended for patients prescribed apixaban in UK only.

Apixaban patient information booklet

This booklet is for your information as you have decided with your doctor to move from warfarin to a Non-VKA Oral Anti-Coagulant (NOAC).

The NOAC you have been prescribed is apixaban for the prevention of stroke in non-valvular atrial fibrillation.

This booklet outlines the steps that you, along with your doctor, will take to safely move from warfarin to apixaban.

Apixaban (ELIQUIS) can also be used to treat other conditions:

If you are unsure what you have been prescribed apixaban for, please check with your doctor as the information in this booklet may not be relevant to you.

booklet for adult patients with nvaf on eliquis (apixaban) for stroke prevention image

This booklet does not replace the patient information leaflet in your medication package which you should always read before you take your medicine. If you have any questions, please discuss with your doctor, nurse or pharmacist.

Please select the language of the Patient Information Booklet you would like to view below:

Blue information icon

Patients prescribed apixaban

This section is intended for patients prescribed apixaban in the UK to provide information on this medicine, and its uses. It is not intended to replace in any way the opinion of a healthcare professional. For specific information about the pathology and/or detection, diagnosis, prognosis, administration and, where applicable, appropriate treatment for each specific case, please promptly consult a healthcare professional. The use of this website is subject to the legal notice, the privacy and cookie policy, the pharmacovigilance notice (if appropriate) and the applicable laws and regulations.

Report Side Effects

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at

Side effects for this medicine should also be reported to Bristol-Myers Squibb Medical Information on 0800 731 1736 or